We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.72B
AUM Growth
+$313M
Cap. Flow
+$128M
Cap. Flow %
4.71%
Top 10 Hldgs %
27.21%
Holding
156
New
12
Increased
32
Reduced
20
Closed
11

Top Buys

Rank Stock Value
1
SEND
SendGrid, Inc.
SEND
+$62.1M
2
ALTR
Altair Engineering Inc
ALTR
+$38.1M
3
ZGNX
Zogenix, Inc.
ZGNX
+$35.9M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$33.5M
5
ARGX icon
argenx
ARGX
+$20.8M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$42M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$29.8M
3
W icon
Wayfair
W
+$28.7M
4
IDTI
Integrated Device Technology I
IDTI
+$26.3M
5
ELLI
Ellie Mae Inc
ELLI
+$25.1M

Sector Composition

Rank Sector Weight
1 Healthcare 45.7%
2 Technology 19.3%
3 Consumer Discretionary 10.25%
4 Industrials 6.97%
5 Communication Services 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKFT
101
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.81B
$4.5M 0.17%
40,000
– –
VBIV
102
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$4.48M 0.16%
61,667
– –
XENE icon
103
Xenon Pharmaceuticals
XENE
$6.2B
$4.16M 0.15%
+315,000
New +$3.65M
DERM
104
DELISTED
Dermira, Inc.
DERM
$3.64M 0.13%
334,000
– –
IRWD icon
105
Ironwood Pharmaceuticals
IRWD
$614M
$3.54M 0.13%
229,248
– –
CRNX icon
106
Crinetics Pharmaceuticals
CRNX
$8.85B
$3.53M 0.13%
+123,225
New +$3.66M
MGNX icon
107
MacroGenics
MGNX
$240M
$3.15M 0.12%
147,000
– –
IOVA icon
108
Iovance Biotherapeutics
IOVA
$2.09B
$3.15M 0.12%
280,000
– –
BEP icon
109
Brookfield Renewable
BEP
$9.9B
$3.12M 0.11%
193,280
+1,877
+1% +$30.8K
ABB
110
DELISTED
ABB Ltd
ABB
$2.92M 0.11%
123,500
+13,000
+12% +$298K
GYRE icon
111
Gyre Therapeutics
GYRE
$648M
$2.65M 0.1%
32,800
– –
TSM icon
112
TSMC
TSM
$2.09T
$2.63M 0.1%
59,500
– –
FHB icon
113
First Hawaiian
FHB
$3.4B
$2.53M 0.09%
93,000
+500
+0.5% +$14.3K
HMC icon
114
Honda
HMC
$39.9B
$2.39M 0.09%
79,500
+3,500
+5% +$104K
JCI icon
115
Johnson Controls International
JCI
$87.8B
$2.17M 0.08%
62,000
-5,500
-8% -$203K
ETN icon
116
Eaton
ETN
$150B
$2.09M 0.08%
24,100
-400
-2% -$32.7K
TERP
117
DELISTED
TerraForm Power, Inc
TERP
$2.08M 0.08%
180,000
+56,500
+46% +$627K
BG icon
118
Bunge Global
BG
$20.4B
$1.96M 0.07%
28,500
+1,000
+4% +$66K
BDN
119
Brandywine Realty Trust
BDN
$525M
$1.8M 0.07%
114,500
– –
SYRS
120
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.79M 0.07%
15,000
– –
MLKN icon
121
MillerKnoll
MLKN
$1.53B
$1.73M 0.06%
45,000
+1,000
+2% +$37.9K
SEP
122
DELISTED
Spectra Engy Parters Lp
SEP
$1.68M 0.06%
47,000
-13,000
-22% -$481K
GPMT
123
Granite Point Mortgage Trust
GPMT
$64.7M
$1.67M 0.06%
86,500
+4,500
+5% +$84.9K
DLPH
124
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$1.65M 0.06%
52,666
– –
ALLK
125
DELISTED
Allakos
ALLK
$1.57M 0.06%
+35,000
New +$1.44M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Eventide Asset Management held 156 positions worth $2.72B, up 13% from $2.41B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $128M of net new capital in Q3 2018, opening 12 new positions and adding to 32 existing holdings. Its largest new stake was SendGrid, Inc.: 1,968,653 shares worth $72.4M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 42% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $42M trimmed.

  • Eventide Asset Management's largest Q3 2018 buy was SendGrid, Inc.: 1,968,653 shares worth $72.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q3 2018, an estimated $35.9M increase.
  • Eventide Asset Management's biggest Q3 2018 reduction was AbbVie, cutting an estimated $42M.
  • Eventide Asset Management fully exited Integrated Device Technology I in Q3 2018, selling an estimated $26.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $2.72B portfolio in Q3 2018.
  • Eventide Asset Management opened 12 new positions and closed 11 in Q3 2018.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $2.72B.

Based on Eventide Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.